U.S. Mortgage Finance Stock News

What the new Employee File Cabinet launch means for BBSI shareholders Barrett Business Services (BBSI) has rolled out its Employee File Cabinet HRIS module within the BBSI Client Portal, built with Box, giving clients a secure, centralized hub for key HR documents. The launch highlights BBSI’s ongoing push to consolidate HR workflows into a single portal experience. The company points to potential benefits around compliance, time savings, and employee access to their own documents. See our...

Calavo Growers (CVGW) just wrapped up FY 2025 with Q4 revenue of US$124.7 million and basic EPS of US$0.21. Trailing 12 month revenue came in at US$648.4 million and EPS at US$1.11, supported by a trailing net profit margin of 3.1% versus 1.0% in the prior year. Over the last few quarters, revenue has ranged from US$154.4 million to US$190.5 million with quarterly EPS between US$0.21 and US$0.38. This points to a picture of improving profitability that puts margins, rather than top line...

If you are wondering whether Douglas Emmett is priced attractively today, or if the share price still does not reflect its underlying real estate assets, this article explains what the current market value might be telling you. The stock recently closed at US$10.97, with returns of a 1.6% decline over 7 days, a 4.8% decline over 30 days, a 0.9% decline year to date, a 32.8% decline over 1 year and a 51.5% decline over 5 years. This performance may have changed how investors view its risk and...

Mereo BioPharma Group recently reported that its Phase 3 Orbit and Cosmic trials of setrusumab in osteogenesis imperfecta missed their primary fracture reduction endpoints but achieved strong statistical improvements in bone mineral density, while also updating investors that its approximately US$41,000,000 cash balance at 31 December 2025 is expected to fund operations to mid-2027. Alongside reassessing the future of setrusumab with partner Ultragenyx, Mereo is pushing ahead with a single...

Apogee Enterprises, Inc.'s ( NASDAQ:APOG ) earnings announcement last week didn't impress shareholders. However, our...

Shareholders in Applied Digital Corporation ( NASDAQ:APLD ) may be thrilled to learn that the analysts have just...

Recently, TD Cowen and UBS both upgraded Enhabit to Buy, signaling a shift in analyst opinion on the home health and hospice provider. This cluster of upgrades suggests large institutions are reassessing Enhabit’s risk‑reward profile in light of its evolving operating backdrop. Next, we’ll examine how this renewed analyst confidence might influence Enhabit’s investment narrative, particularly around reimbursement resilience and growth. AI is about to change healthcare. These 30 stocks are...

As the United States stock market experiences a resurgence, with major indices like the Nasdaq, Dow Jones Industrial Average, and S&P 500 climbing on strong tech earnings and easing geopolitical tensions, investors are increasingly focused on identifying opportunities that may be undervalued. In this environment of fluctuating oil prices and robust tech performance, discerning stocks that are priced below their estimated value can offer potential advantages for those looking to capitalize on...

As the U.S. stock market experiences a surge, driven by strong performances in the tech sector and easing geopolitical tensions, investors are keenly observing growth companies that insiders are backing with significant ownership stakes. In this environment of rising indices and fluctuating oil prices, stocks with high insider ownership can offer an added layer of confidence for investors seeking to align with those who have intimate knowledge of their company's potential.

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Daktronics, Inc.'s ( NASDAQ:DAKT ) price-to-sales (or "P/S") ratio of 1.4x might make it look like a buy right now...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...

Phoenix Education Partners (PXED) has drawn fresh attention after recent trading left the stock at US$28.39. Negative returns over the past week, month, past 3 months, and year to date are prompting closer scrutiny. See our latest analysis for Phoenix Education Partners. The recent 10.47% one day share price decline caps a broader loss of momentum, with the 90 day share price return of 20.48% and year to date share price return of 4.31% both in negative territory. If Phoenix Education...

As of January 2026, the U.S. stock market is experiencing a period of volatility, with major indices such as the Dow Jones Industrial Average and S&P 500 closing lower amid investor concerns over inflation data and earnings reports from key financial institutions. Despite these fluctuations, high-growth tech stocks continue to capture attention due to their potential for innovation and resilience in adapting to evolving economic conditions; identifying strong candidates often involves...

JFB Construction Holdings ( NASDAQ:JFB ) shareholders have had their patience rewarded with a 30% share price jump in...

Bitdeer Technologies Group ( NASDAQ:BTDR ) shareholders are no doubt pleased to see that the share price has bounced...

BitFuFu Inc. ( NASDAQ:FUFU ) shareholders are no doubt pleased to see that the share price has bounced 28% in the last...

Hyperfine, Inc. ( NASDAQ:HYPR ) shareholders are no doubt pleased to see that the share price has bounced 34% in the...

Key Insights The considerable ownership by private equity firms in Greenfire Resources indicates that they collectively...

Torrid Holdings Inc. ( NYSE:CURV ) shareholders are no doubt pleased to see that the share price has bounced 33% in the...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Ouster, Inc. ( NASDAQ:OUST ) shareholders are no doubt pleased to see that the share price has bounced 26% in the last...

Key Insights Given the large stake in the stock by institutions, Protara Therapeutics' stock price might be vulnerable...